TickerGuard
Buy Day today: Good (67) Broad market participation · no major macro event

Artiva Biotherapeutics, Inc. Common Stock (ARTV)

Healthcare Biotechnology
10.80 $
+6.5% vs. previous close
Closing price · As of: 3. Aug 2026

Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Artiva Biotherapeutics, Inc. Common Stock (ARTV) with date, type and a link to the original document.

Filings ARTV
Date Type Filing Original
07/22/2026 Current report (8-K) Artiva Biotherapeutics, Inc. (ARTV): Other Events View report →

Showing the 100 most recent filings of the selected type.

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?